Abstract
The aim is to develop and validate a specific instrument for measuring satisfaction with anxiolytic and hypnotic drug treatment. We determined the questionnaire’s convergent validity with respect to clinical effectiveness, tolerance, and treatment adherence. An observational study was conducted in 171 patients being treated with anxiolytic/hypnotic medications. The questionnaire to assess Treatment Satisfaction with Anxiolytics and Hypnotics (TSAN) was evaluated for reliability, construct validity, and correlation with measurements conceptually related to the said construct. The average score on the TSAN questionnaire was 42.6 points (SD: 8.4), showing a moderate negative correlation with respect to scores obtained on the Goldberg Anxiety (−0.312) and Athens Insomnia (−0.419) scales. The TSAN questionnaire is valid and reliable. It constitutes a patient-centered measurement tool that complements clinical evaluation of the effectiveness of anxiolytic/hypnotic drug treatment.
Similar content being viewed by others
References
Agencia Española de Medicamentos y Productos Sanitarios. (2014). Utilización de medicamentos ansiolíticos e hipnóticos en España durante el periodo 2000-2012. Ministerio de Sanidad, Servicios Sociales e Igualdad [consulted 20/12/2016]. Available in: https://www.aemps.gob.es/medicamentosUsoHumano/observatorio/docs/ansioliticos_hipnoticos-2000-2012.pdf.
Alomar, A., Guerra, A., Perulero, N., Badia, X., Canals, L., & Álvarez, C. (2004). Desarrollo de un cuestionario de evaluación de la satisfacción con el tratamiento en pacientes con acné. Actas Dermosifilográficas, 95(8), 491–495. https://doi.org/10.1016/S0001-7310(04)76865-9.
Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Brod, M., & Rowland, C. R. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health and Quality of Life Outcomes, 2, 12.
Badia, X. (2005). La satisfacción con el tratamiento. Medicina Clínica (Barc), 125, 98–99.
Baro, E., Casado, A., Garcia-Cases, C., Clerch, L., & Ribas, S. (2004). Assessing satisfaction with pain medication in primary care patients: Development and psychometric validation of a new measure. Clinical Therapeutics, 26(7), 1124–1136. https://doi.org/10.1016/s0149-2918(04)90185-3.
Bejarano Romero, F., Piñol Moreso, J. L., Mora Gilabert, N., Claver Luque, P., Brull López, N., & Basora Gallisa, J. (2008). Elevado consumo de benzodiacepinas en mujeres ancianas asignadas a centros de salud urbanos de atención primaria. Atencion Primaria, 40(12), 617–621.
Carbonell, J., Badia, X., & Grupo EXPRESAR. (2006). Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide. Reumatología Clínica, 2(3), 137–145. https://doi.org/10.1016/S1699-258X(06)73035-2.
Escrivá Ferrairó, R., Pérez Díez, A., Lumbreras García, C., Molina París, J., Sanz Cuesta, T., & Corral Sánchez, M. A. (2000). Prescripción de benzodiacepinas en un centro de salud: Prevalencia, cómo es su consumo y características del consumidor. Atención Primaria, 25(2), 107–110. https://doi.org/10.1016/S0212-6567(00)78472-1.
Galleguillos, T., Risco, L., Garay, J. L., González, M., & Vogel, M. (2003). Trends in benzodiazepine use in primary care patients. Revista Médica de Chile, 131(5), 535–540.
Garzón Maldonado, F. J., Gutiérrez Bedmar, M., García Casares, N., Pérez Errázquin, F., Gallardo Tur, A., & Martínez Valle Torres, M. D. (2017). Health-related quality of life in caregivers of patients with Alzheimer disease. Neurología, 32(8), 508–515.
Grupo de Trabajo de la Guía de Práctica Clínica para el Manejo de Pacientes con Insomnio en Atención Primaria. Guía de Práctica Clínica para el Manejo de Pacientes con Insomnio en Atención Primaria. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social. Unidad de Evaluación de Tecnologías Sanitarias. Agencia Laín Entralgo. Comunidad de Madrid; 2009. Guías de Práctica Clínica en el SNS: UETS N° 2007/5–1.
Johnson, C. F., Frei, C., Downes, N., McTaggart, S. A., & Akram, G. (2016). Benzodiazepine and z-hypnotic prescribing for older people in primary care: A cross-sectional population-based study. British Journal of General Practice, 66(647), e410–e415. https://doi.org/10.3399/bjgp16X685213.
Kapil, V., Green, J. L., Le Lait, C., Wood, D. M., & Dargan, P. I. (2014). Misuse of benzodiazepines and Z-drugs in the UK. British Journal of Psychiatry, 205(5), 407–408. https://doi.org/10.1192/bjp.bp.114.149252.
Kjosavik, S. R., Ruths, S., & Hunskaar, S. (2012). Use of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway. European Journal of Clinical Pharmacology, 68(3), 311–319. https://doi.org/10.1007/s00228-011-1124-2.
Liner-Pelz, S. (1982). Toward a theory of patient satisfaction. Social Science & Medicine, 16(5), 577–582. https://doi.org/10.1016/0277-9536(82)90311-2.
López-Torres Hidalgo, J., López Gallardo, Y., Párraga Martínez, I., Del Campo del Campo, J. M., Villena Ferrer, A., & Morena Rayo, S. (2013). Satisfacción con el tratamiento antidepresivo. Validación del cuestionario “ESTA”. Revista Española de Salud Pública, 87, 615–627. https://doi.org/10.4321/S1135-57272013000600006.
Luder, M., Tylee, A., & Donoghue, J. (2009). Withdrawing benzodiazepines in primary care. CNS Drugs, 23(1), 19–34.
Martín Pérez, C., Pedrosa García, R., Herrero Martín, J. J., Luna del Castillo, J. D., Ramírez García, P., & Sáez García, J. M. (2003). Prevalencia de psicopatías en un centro de salud rural. Atención Primaria, 31(1), 39–46.
Ormel, J., Vonkorff, M., Ustun, T. B., Pini, S., Korten, A., & Oldehinkel, T. (1994). Common mental disorders and disability across cultures. Results from the WHO collaborative study on psychological problems in general health care. JAMA, 272(22), 1741–1748. https://doi.org/10.1001/jama.272.22.1741.
Paddock, L. E., Veloski, J., Chatterton, M. L., Gevitz, F. O., & Nash, D. B. (2000). Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management. Diabetes Care, 23(7), 951–956. https://doi.org/10.2337/diacare.23.7.951.
Sarrais, F., & de Castro Manglano, P. (2007). El insomnio. Anales del Sistema Sanitario de Navarra, 30(Supl. 1), 121–134.
Taylor, T. R. (2000). Understanding the choices that patients make. The Journal of the American Board of Family Practice, 13(2), 124–133.
Vedia Urgell, C., Bonet Monne, S., Forcada Vega, C., & Parellada, E. N. (2005). Estudio de utilización de psicofármacos en atención primaria. Atención Primaria, 36(5), 239–245. https://doi.org/10.1157/13079144.
Velert Villa, J., Velert Vila, M. M., Salar Ibáñez, L., Avellana Zaragoza, J. A., & Moreno Royo, L. (2012). Suitability of the use of benzodiazepines prescribed by the pharmacist in the elderly. A doctor-pharmacist collaboration study. Atencion Primaria, 44(7), 402–410.
Vicente Sánchez, M. P., Macías Saint-Gerons, D., De la Fuente Honrubia, C., González Bermejo, D., Montero-Corominas, D., & Catalá-López, F. (2013). Evolución del uso de medicamentos ansiolíticos e hipnóticos en España durante el periodo 2000-2011. Revista Española de Salud Pública, 87, 247–255. https://doi.org/10.4321/S1135-57272013000300004.
Weaver, M., Markson, P. D., Frederich, M. D., & Berger, M. (1997). Issues in the management of treatment satisfaction. American Journal of Managed Care, 3(4), 579–594.
Wrigh, J. G. (2000). Evaluating the outcome of treatment. Shouldn’ t be asking patients if they are better? Journal of Clinical Epidemiology, 53(6), 549–553.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
The work was approved by the Clinical Research Ethics Committee of the Health Area of Albacete.
The authors have complied with the ethical standards relevant to the publication.
Informed Consent
The authors have the informed consent of the patients.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOC 42 kb)
Rights and permissions
About this article
Cite this article
García-Atienza, E.M., López-Torres Hidalgo, J., Minuesa-García, M. et al. Satisfaction with Anxiolytic and Hypnotic Drug Treatment: Validation of the TSAN Questionnaire. Int J Ment Health Addiction 20, 2599–2608 (2022). https://doi.org/10.1007/s11469-021-00533-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11469-021-00533-y